摘要
淋巴瘤是原发于淋巴系统的恶性肿瘤,分为霍奇金淋巴瘤和非霍奇金淋巴瘤。其中非霍奇金淋巴瘤(non-Hodgkin lymphoma,NHL)占整个淋巴瘤的90%。NHL种类繁多,不同的淋巴瘤有不同的治疗原则。目前常用的治疗指南有欧洲肿瘤内科学会(European Society for Medical Oncology)指南、美国国立综合癌症网络(National Comprehensive Cancer Network)诊治指南和我国的淋巴瘤诊治规范。我们将结合这3个指南对NHL的治疗现状进行介绍。
Lymphoma is a malignant tumor of the lymphatic system which can be divided into Hodgkin lymphoma and non Hodgkin lymphoma（NHL）.The NHL accounts for 90% of total lymphomas.NHL is a heterogeneous group of lymphoproliferative disorders including different subtypes which have different therapeutic principles.The European Society for Medical Oncology guidelines,National Comprehensive Cancer Network guidelines of the United States and the diagnosis and treatment guidelines of lymphoma of China are the primary guidelines at present in our country.The following discussion will focus on the current treatment of NHL combining these three guidelines.
出处
《临床荟萃》
CAS
2015年第10期1110-1119,共10页
Clinical Focus
关键词
淋巴瘤
非霍奇金
诊断
治疗
lymphoma
non-hodgkin
diagnosis
therapy
作者简介
通信作者：魏旭东，Email：weixudong63@126．com
